ResMed (WBO:RMD) Cyclically Adjusted Book per Share: €22.39 (As of Mar. 2026)


WBO:RMD ResMed Inc WBO:RMD
96 GF Score
Price €188.85
GF Value €236.61
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is ResMed Cyclically Adjusted Book per Share?

ResMed WBO:RMD +2.08% 96 Cyclically Adjusted Book per Share is €22.39 as of Mar. 2026. GuruFocus rates WBO:RMD with a GF Score™ of 96/100 and a GF Value™ of €236.61 (Modestly Undervalued). The stock has 1 warning sign investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

ResMed's adjusted book value per share for the three months ended in Mar. 2026 was €38.717. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €22.39 for the trailing ten years ended in Mar. 2026.

During the past 12 months, ResMed's average Cyclically Adjusted Book Growth Rate was 15.50% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 11.30% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 11.70% per year. During the past 10 years, the average Cyclically Adjusted Book Growth Rate was 9.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of ResMed was 32.00% per year. The lowest was 6.90% per year. And the median was 13.00% per year.

As of today (2026-07-07), ResMed's current stock price is €188.85. ResMed's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was €22.39. ResMed's Cyclically Adjusted PB Ratio of today is 8.43.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of ResMed was 19.96. The lowest was 5.54. And the median was 10.57.


ResMed  (WBO:RMD) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

ResMed's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=188.85/22.39
=8.43

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of ResMed was 19.96. The lowest was 5.54. And the median was 10.57.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


ResMed Cyclically Adjusted Book per Share Related Terms


ResMed Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for ResMed's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ResMed Cyclically Adjusted Book per Share Chart

ResMed Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 12.32 16.37 17.08 19.38 19.86

ResMed Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 20.57 19.86 20.80 21.78 22.39

WBO:RMD vs MDLN, WST, BDX: Cyclically Adjusted Book per Share Comparison

For the Medical Instruments & Supplies subindustry, ResMed's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ResMed Cyclically Adjusted PB Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, ResMed's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where ResMed's Cyclically Adjusted PB Ratio falls into.


WBO:RMD
96GF Score
ResMed Inc WBO:RMD
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

ResMed Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, ResMed's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=38.717/330.2130*330.2130
=38.717

Current CPI (Mar. 2026) = 330.2130.

ResMed Quarterly Data

Book Value per Share CPI Adj_Book
201606 10.724 241.018 14.693
201609 11.210 241.428 15.332
201612 11.448 241.432 15.658
201703 12.233 243.801 16.569
201706 12.271 244.955 16.542
201709 12.087 246.819 16.171
201712 11.943 246.524 15.997
201803 11.745 249.554 15.541
201806 12.353 251.989 16.188
201809 11.429 252.439 14.950
201812 12.000 251.233 15.772
201903 12.479 254.202 16.210
201906 12.766 256.143 16.458
201909 13.372 256.759 17.197
201912 14.055 256.974 18.061
202003 14.116 258.115 18.059
202006 15.304 257.797 19.603
202009 15.695 260.280 19.912
202012 16.185 260.474 20.518
202103 15.639 264.877 19.497
202106 16.445 271.696 19.987
202109 17.652 274.310 21.249
202112 19.041 278.802 22.552
202203 20.354 287.504 23.378
202206 21.715 296.311 24.199
202209 23.674 296.808 26.338
202212 24.022 296.797 26.727
202303 24.999 301.836 27.349
202306 25.920 305.109 28.053
202309 27.077 307.789 29.050
202312 27.942 306.746 30.080
202403 28.999 312.332 30.659
202406 30.760 314.175 32.330
202409 31.890 315.301 33.398
202412 34.160 315.605 35.741
202503 34.990 319.799 36.129
202506 35.346 322.561 36.185
202509 35.736 324.800 36.332
202512 37.059 324.054 37.763
202603 38.717 330.213 38.717

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of €22.39 mean?
ResMed (WBO:RMD) has a Cyclically Adjusted Book per Share of €22.39 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on ResMed and its competitors.
Is ResMed's Cyclically Adjusted Book per Share too high?
ResMed's current Cyclically Adjusted Book per Share is €22.39. Overall, ResMed has a GF Score™ of 96/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does ResMed's Cyclically Adjusted Book per Share compare to MDLN and WST?
ResMed's Cyclically Adjusted Book per Share of €22.39 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted Book per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on ResMed and its competitors. ResMed's current Cyclically Adjusted Book per Share is €22.39. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ResMed stock overvalued right now?
Based on GuruFocus' analysis, ResMed (WBO:RMD) is currently considered Modestly Undervalued. The stock's GF Value™ is €236.61, compared to a current price of €188.85 — trading 20.2% below its estimated fair value. The current Cyclically Adjusted Book per Share is €22.39. ResMed's overall GF Score™ is 96/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For ResMed (WBO:RMD), the current Cyclically Adjusted Book per Share is €22.39 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is ResMed (WBO:RMD) Overvalued in 2026?

Based on GuruFocus' analysis, ResMed stock appears to be undervalued. The current stock price of €188.85 is trading 20.2% below its estimated GF Value™ of €236.61. GuruFocus considers ResMed to be Modestly Undervalued.

Key valuation signals for WBO:RMD:

  • Cyclically Adjusted Book per Share: €22.39
  • GF Value™: €236.61 vs. price of €188.85 (20.2% below fair value)
  • GF Score™: 96/100 with 1 warning sign

No single metric tells the full story. See the WBO:RMD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


ResMed Business Description

Address 9001 Spectrum Center Boulevard, San Diego, CA, USA, 92123
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks, and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with aging populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two-thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan, and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor, and payer in the out-of-hospital setting.
96GF Score

Get the complete analysis for WBO:RMD

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€188.85
Price
€236.61
GF Value